Biogen Inc. Chief Executive Michel Vounatsos will resign from the company as it slims down its workforce and cuts spending by $1 billion annually.
Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease. WSJ explains how the drug interacts with brain cells, and why some doctors aren’t ready to prescribe it yet. Illustration: Jacob ReynoldsBiogen Inc.
Chief Executive Michel Vounatsos will resign from the company as it slims down its workforce, cuts spending by $1 billion annually and attempts to chart a new course after Medicare’s devastating refusal to coverBiogen said Tuesday that Mr. Vounatsos would continue to lead the company and remain on its board until a search for a new CEO is completed.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Change at the top for Biogen after Alzheimer's drug flopsBiogen is looking for a new CEO less than a year after its launch of its Alzheimer’s drug Aduhelm largely fizzled. The company said Tuesday that current CEO Michel Vounatsos will continue to lead the company until his successor is appointed.
Consulte Mais informação »
Steps star Claire Richards admits she 'struggles everyday' to keep slim figureSteps star Claire Richards has revealed she still struggles with her body image and admits she previously went from 'dangerously thin' to 'obese'
Consulte Mais informação »
Using WordPress Quizzes for Amazon Alexa Trivia Skills | HackerNoonA quick step-by-step guide on making voice trivia quizzes through a GUI in WordPress.
Consulte Mais informação »
Pink Opens Up About Personal Mental Health Struggles In Newly Launched Dare To Share Campaign'There are beautiful moments waiting for you, & there are beautiful people waiting to love you, and one of those people is yourself.' Pink shares her experience with mental health struggles in childmindinst's new Dare to Share campaign ⬇
Consulte Mais informação »
Arizona’s ‘Right to Try 2.0’In 2018, former President Donald Trump signed into law a bill that gave terminally ill patients the right to try experimental drugs not yet approved by the U.S. Food and Drug Administration.
Consulte Mais informação »
Combat death puts spotlight on Americans fighting in UkraineA former U.S. Marine who died last week in Ukraine was believed to be the first American citizen killed while fighting there.
Consulte Mais informação »